Immediate Impact

52 standout
Sub-graph 1 of 22

Citing Papers

Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
3 intermediate papers

Works of Stef Meers being referenced

Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
2022
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
2009

Author Peers

Author Last Decade Papers Cites
Stef Meers 98 52 8 218 173 22 404
J. Rodrı́guez-Molina 82 32 6 183 41 23 452
Francis Ayuk 209 78 20 71 75 27 458
Lewis H. Dennis 114 63 150 51 44 21 428
J.-M. Durand 101 45 39 81 49 28 429
Katie R. Pang 37 15 13 203 119 18 434
Baldeep Wirk 132 23 16 89 59 32 337
Janice Brown 49 9 16 297 120 13 361
Vinay Shanker 24 19 93 157 95 31 382
A. Insunza 160 72 24 60 46 24 360
Hayato Yamauchi 58 50 57 55 67 40 414

All Works

Loading papers...

Rankless by CCL
2026